
Anne Connolly
Robert F. and Edgar T. Wolfe Foundation Endowed Chair in Neurology · Nationwide Children's Hospital
Credentials: · · · ·
History
Research
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
New England Journal of Medicine · 2017 · 1,769 citations
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
New England Journal of Medicine · 2018 · 1,080 citations
The Lancet Neurology · 2021 · 399 citations

28 papers

26 papers
- AP
25 papers

24 papers

19 papers

19 papers
- BD
16 papers

16 papers
Grants
- 2023–2028
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $3.8M · Research Inst Nationwide Children's Hosp
- 2005–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $1.4K · Washington University
- 1993–1999
Humoral Immune Mechanisms in Polyneuropathies
National Institute of Neurological Disorders and Stroke · K08
Contact PI · $405.7K · Washington University
Clinical trials
- 2025–2028
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
Principal investigator · Recruiting
Nationwide Children's Hospital
- 2021–2028
Once Weekly Infant Corticosteroid Trial for DMD
Principal investigator · Recruiting · Phase 4
Anne M. Connolly
- 2014–2017
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Principal investigator · Completed · Phase 2
Washington University School of Medicine
- 2010–2013
Principal investigator · Completed
Washington University School of Medicine





